Pacific Biomarkers, Inc. (PBME.OB) Announces Quarterly Results

In the company’s news Friday,

Pacific Biomarkers Inc. reported its financial results for the second quarter of FY2010, together with first half results for the fiscal year.

Revenue for the three months ended December 31, 2009 (their second quarter FY2010), decreased 35%, to $2,113,795, compared with the same quarter last year, and decreased 8% compared with the previous quarter. The company reported an operating loss of $307,037 (and net loss of $457,629) for the quarter, versus an operating income of $554,505 (and net income of $976,671) for the same quarter last year.

First half results for the fiscal year showed a 12% decrease in revenue, to $4,415,170, compared with the first half of the previous fiscal year. They also showed an operating loss of $520,745 for the half, versus an operating income of $341,133 for the first half of the previous fiscal year, and showed a net loss of $730,799 for the half, versus a net income of $970,934 for the first half of the previous fiscal year.

Pacific CEO, Ron Helm, commented on the downturn. “Our results for the three months ended December 31, 2009 are a reflection of the challenging drug development environment. Although revenue fell short of the prior year, we remain confident that we are well positioned to execute our strategic plan for continued growth in the specialty laboratory business and our biomarker services area. We have seen changes in our clinical services market in line with what other Contract Research Organizations (CROs) have reported, which have affected current revenues.”

Mr. Helm emphasized the company’s continued strong position, in spite of the recent losses. “The Company’s exceptional result last year showed that our strategy of broadening our biomarker services offering was a sound move. The current market conditions may challenge us for a time and we are taking appropriate measures to control costs and realign our business to enhance our support of our clients. We believe we will be positioned appropriately as the market improves. Despite our operating loss, we still ended the quarter with a strong balance sheet. Cash and cash equivalents totaled $3,264,024 as of December 31, 2009 and we have an additional $502,237 in short term investments, which totals $3,766,261.”

He concluded, “We believe PBI’s soft financial performance for the first half of Fiscal 2010 will not continue during the second half of Fiscal 2010. We are encouraged that our expected backlog entering fiscal 2011 will be greater than any previous year.”

About QualityStocks

QualityStocks, based in Scottsdale, Arizona is a free service that collects data from hundreds Small-Cap and Micro-Cap online Investment Newsletters into one Free Daily Newsletter Report. QualityStocks is dedicated to assisting emerging public companies with their advertising efforts and now has over 750,000+ subscribers that receive The Daily Stock Newsletters.

To sign up for “The QualityStocks Daily Newsletter” please visit http://www.qualitystocks.net/

Please see disclaimer on QualityStocks website: http://Disclaimer.QualityStocks.net 

Forward-Looking Statement:

This release may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All forward-looking statements are inherently uncertain as they are based on current expectations and assumptions concerning future events or future performance of the company. Readers are cautioned not to place undue reliance on these forward-looking statements, which are only predictions and speak only as of the date hereof. Risks and uncertainties applicable to the company and its business could cause the company's actual results to differ materially from those indicated in any forward-looking statements.